Your browser doesn't support javascript.
loading
The discovery of the Factor Xa inhibitor otamixaban: from lead identification to clinical development.
Guertin, Kevin R; Choi, Yong-Mi.
Affiliation
  • Guertin KR; Department of Discovery Chemistry, Roche Research Center, 340 Kingsland St., Nutley, New Jersey 07110, USA. Kevin.Guertin@Roche.com
Curr Med Chem ; 14(23): 2471-81, 2007.
Article in En | MEDLINE | ID: mdl-17979700
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Cyclic N-Oxides / Factor Xa Inhibitors Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2007 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Cyclic N-Oxides / Factor Xa Inhibitors Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2007 Document type: Article Affiliation country: Country of publication: